Search engine for other government resources

Bevacizumab - National Cancer Institute

Bevacizumab is also being studied in the treatment of other types of cancer. More About Bevacizumab. Definition from the NCI Drug Dictionary - ...
www.cancer.gov/about-cancer/treatment/drugs/bevacizumab

Bevacizumab - PubMed Central PMC

Bevacizumab is a clear, colorless solution administered i.v. [2, 3] in combination with chemotherapy in doses of 5, 7.5, 10, or 15 mg/kg as shown in ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC3228024/

Bevacizumab Injection MedlinePlus Drug Information

Bevacizumab injection products come as a solution (liquid) to administer slowly into a vein. Bevacizumab injection products are administered by a ...
medlineplus.gov/druginfo/meds/a607001.html

CPI-613 Devimistat in Combination With Modified ...

Dose-limiting toxicities assessed in order to be able to establish safety and tolerability for the combination of CPI-613, mFFX with bevacizumab ...
clinicaltrials.gov/ct2/show/NCT05070104

Bevacizumab Avastin in cancer treatment A review of 15 ...

When the VEGF-A-targeting monoclonal antibody bevacizumab (Avastin) entered clinical practice more than 15 years ago, it was one of the first ...
pubmed.ncbi.nlm.nih.gov/32335505/

When Combined with Chemotherapy Bevacizumab Is Associated ...

Cancer patients who receive the targeted therapy bevacizumab (Avastin) in combination with chemotherapy are at increased risk of serious side effects ...
www.cancer.gov/types/colorectal/research/bevacizumab-severe-side-effects

Efficacy and safety of bevacizumab in active brain ...

Bevacizumab is effective for the treatment of non-small cell lung cancer (NSCLC). Ongoing trials are exploring the safety of bevacizumab in patients ...
pubmed.ncbi.nlm.nih.gov/20440540/

The role of bevacizumab in the treatment of glioblastoma

Bevacizumab has been used in patients with GBM as a salvage therapy since its approval in the United States for recurrent GBM in 2009. In order to ...
pubmed.ncbi.nlm.nih.gov/28527008/

Using Genetic Profile to Determine the Treatment for ...

Cohort B: Participants who have certain gene changes will receive paclitaxel, bevacizumab, and dostarlimab. Cohort C: If the participant and the study ...
www.clinicaltrials.gov/ct2/show/NCT05065021

History of Changes for Study NCT02997228

Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal ...
clinicaltrials.gov/ct2/history/NCT02997228?V_466=View

DailyMed - AVASTIN- bevacizumab injection solution

Bevacizumab has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e

Avastin bevacizumab Information FDA

Avastin is an injectable cancer medication that works by blocking a protein that is important for the formation of blood vessels. Since tumors rely on ...
www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/avastin-bevacizumab-information

History of Changes for Study NCT02839707

Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. It is not yet known which combination will ...
clinicaltrials.gov/ct2/history/NCT02839707?V_381=View

Bevacizumab and breast cancer current therapeutic ...

Bevacizumab is a humanized monoclonal antibody to VEGF, and the incorporation of bevacizumab to chemotherapy is one of the rapidly evolving areas in ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC2819039/

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION ...

on a first-line bevacizumab product-containing regimen. (1.1) Limitations of Use: MVASI is not indicated for adjuvant treatment of colon cancer. (1.1) ...
www.accessdata.fda.gov/drugsatfda_docs/label/2019/761028s004lbl.pdf

FDA approves bevacizumab in combination with chemotherapy ...

On June 13, 2018, the Food and Drug Administration approved bevacizumab (Avastin, Genentech, Inc.) for patients with epithelial ovarian, fallopian ...
www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-bevacizumab-combination-chemotherapy-ovarian-cancer

Efficacy and safety of bevacizumab treatment for ...

The treatment regimen of bevacizumab was adjusted depending on the neurological symptoms of patients, such as dizziness, fatigue, and headache. The ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC5682776/

Efficacy and Safety of Regorafenib Combined with ...

These patients had previously received at least second-line treatment; the regimens were oxaliplatin and irinotecan-based chemotherapy and/or ...
pubmed.ncbi.nlm.nih.gov/34603452/

Bevacizumab Avastin a humanized anti-VEGF monoclonal ...

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35. doi ...
pubmed.ncbi.nlm.nih.gov/15961063/

Bevacizumab-induced serious side-effects a review of the ...

Purpose: Bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor, is widely used in association with standard ...
pubmed.ncbi.nlm.nih.gov/22349162/